Anja van der Wal
The Netherlands Cancer Institute(NL)
Publications by Year
Research Areas
Cancer-related Molecular Pathways, DNA Repair Mechanisms, Cancer Immunotherapy and Biomarkers, Advanced biosensing and bioanalysis techniques, Genomics and Chromatin Dynamics
Most-Cited Works
- → Fancm-deficient mice reveal unique features of Fanconi anemia complementation group M(2009)149 cited
- → Generation of a mouse mutant by oligonucleotide-mediated gene modification in ES cells(2006)49 cited
- → Fancf‐deficient mice are prone to develop ovarian tumours(2011)35 cited
- → Temozolomide Increases the Number of Mismatch Repair–Deficient Intestinal Crypts and Accelerates Tumorigenesis in a Mouse Model of Lynch Syndrome(2014)30 cited
- DNA mismatch repair deficiency stimulates N-ethyl-N-nitrosourea-induced mutagenesis and lymphomagenesis.(2003)
- → Impact of personalized response-directed surgery and adjuvant therapy on survival after neoadjuvant immunotherapy in stage III melanoma: Comparison of 3-year data from PRADO and OpACIN-neo(2024)21 cited
- → RB Family Tumor Suppressor Activity May Not Relate to Active Silencing of E2F Target Genes(2014)15 cited
- → Gene Modification in Embryonic Stem Cells by Single-Stranded DNA Oligonucleotides(2009)11 cited
- → Survival update of neoadjuvant ipilimumab + nivolumab in macroscopic stage III melanoma: The OpACIN and OpACIN-neo trials.(2022)9 cited
- → Data Supplement from RB Family Tumor Suppressor Activity May Not Relate to Active Silencing of E2F Target Genes(2023)